Exchange: SIX Industry: Health Care Equipment & Services
0.46% CHF330.50
America/New_York / 2 mai 2024 @ 06:50
FUNDAMENTALS | |
---|---|
MarketCap: | 4 504.71 mill |
EPS: | 5.33 |
P/E: | 62.01 |
Earnings Date: | May 22, 2024 |
SharesOutstanding: | 13.63 mill |
Avg Daily Volume: | 0.0162 mill |
RATING 2024-05-02 |
---|
A+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Buy | |
DE: | Buy | |
P/E: | Buy | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 3/23 | |
Revenue | n/a | n/a | n/a | n/a | ||
Gr.Profit | n/a | n/a | n/a | n/a | ||
Ebit | n/a | n/a | n/a | n/a | ||
Asset | n/a | n/a | n/a | n/a | ||
Debt | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
2.45x |
Company: PE 62.01 | sector: PE 25.29 |
PE RATIO: COMPANY / INDUSTRY |
---|
1.27x |
Company: PE 62.01 | industry: PE 48.79 |
DISCOUNTED CASH FLOW VALUE |
---|
CHF-83.19 (-125.17%) CHF-413.69 |
Date: 2024-05-02 |
Expected Trading Range (DAY) |
---|
CHF 320.81 - 340.19 ( +/- 2.93%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | CHF330.50 (0.46% ) |
Volume | 0.0042 mill |
Avg. Vol. | 0.0162 mill |
% of Avg. Vol | 26.07 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.